These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27121258)

  • 1. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer.
    Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J
    Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
    Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
    Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
    Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
    Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microsatellite polymorphism in IGF1 gene promoter and timing of natural menopause in Caucasian women.
    Kaczmarek M; Pacholska-Bogalska J; Kwaśniewski W; Kotarski J; Halerz-Nowakowska B; Goździka-Józefiak A
    Int J Med Sci; 2015; 12(1):32-41. PubMed ID: 25552916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
    Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.
    Kwasniewski W; Gozdzicka-Jozefiak A; Kotarska M; Polak G; Barczynski B; Broniarczyk J; Nowak W; Wolun-Cholewa M; Kwasniewska A; Kotarski J
    Mol Med Rep; 2015 Feb; 11(2):766-74. PubMed ID: 25384883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
    Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
    Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.
    Merritt MA; Strickler HD; Einstein MH; Yang HP; Sherman ME; Wentzensen N; Brouwer-Visser J; Cossio MJ; Whitney KD; Yu H; Gunter MJ; Huang GS
    Cancer Causes Control; 2016 Jun; 27(6):737-48. PubMed ID: 27125830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
    Costalonga EF; Antonini SR; Guerra G; Coletta RR; Franca MM; Braz AF; Mendonca BB; Arnhold IJ; Jorge AA
    Pharmacogenomics J; 2012 Oct; 12(5):439-45. PubMed ID: 21468024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.
    McGrath M; Lee IM; Buring J; De Vivo I
    Gynecol Oncol; 2011 Feb; 120(2):174-8. PubMed ID: 21078522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
    Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
    Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the P1 promoter of the IGF-1 gene in children with growth disorders.
    Broniarczyk JK; Kędzia A; Nowak W; Kościński Ł; Lewandowski M; Goździcka-Józefiak A
    Pediatr Endocrinol Diabetes Metab; 2015; 20(4):136-42. PubMed ID: 26615580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
    Ye P; Qu CF; Hu XL
    Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
    Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulinlike Growth Factor-1 and Its Binding Protein-3 Polymorphisms Predict Circulating IGF-1 Level and Appendicular Skeletal Muscle Mass in Chinese Elderly.
    Yang CW; Li TC; Li CI; Liu CS; Lin CH; Lin WY; Lin CC
    J Am Med Dir Assoc; 2015 May; 16(5):365-70. PubMed ID: 25548030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of
    Doria PLS; Moscovitz T; Tcherniakovsky M; Fernandes CE; Pompei LM; Wajman M; Nimwegen AV; Haimovich S
    Biomed Res Int; 2018; 2018():8704346. PubMed ID: 30643822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.
    Chen W; Wang S; Tian T; Bai J; Hu Z; Xu Y; Dong J; Chen F; Wang X; Shen H
    Eur J Hum Genet; 2009 Dec; 17(12):1668-75. PubMed ID: 19491931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly.
    Sala E; Filopanti M; Ferrante E; Barbieri AM; Malchiodi E; Verrua E; Giavoli C; Lania AG; Arosio M; Beck-Peccoz P; Spada A; Mantovani G
    Eur J Clin Invest; 2014 Dec; 44(12):1222-9. PubMed ID: 25370837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.